Correlation Between Vaccinex and Brainstorm Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Brainstorm Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Brainstorm Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Brainstorm Cell Therapeutics, you can compare the effects of market volatilities on Vaccinex and Brainstorm Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Brainstorm Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Brainstorm Cell.

Diversification Opportunities for Vaccinex and Brainstorm Cell

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vaccinex and Brainstorm is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Brainstorm Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brainstorm Cell Ther and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Brainstorm Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brainstorm Cell Ther has no effect on the direction of Vaccinex i.e., Vaccinex and Brainstorm Cell go up and down completely randomly.

Pair Corralation between Vaccinex and Brainstorm Cell

Given the investment horizon of 90 days Vaccinex is expected to under-perform the Brainstorm Cell. But the stock apears to be less risky and, when comparing its historical volatility, Vaccinex is 1.19 times less risky than Brainstorm Cell. The stock trades about -0.03 of its potential returns per unit of risk. The Brainstorm Cell Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  245.00  in Brainstorm Cell Therapeutics on September 4, 2024 and sell it today you would lose (74.00) from holding Brainstorm Cell Therapeutics or give up 30.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vaccinex  vs.  Brainstorm Cell Therapeutics

 Performance 
       Timeline  
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Vaccinex is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Brainstorm Cell Ther 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Vaccinex and Brainstorm Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaccinex and Brainstorm Cell

The main advantage of trading using opposite Vaccinex and Brainstorm Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Brainstorm Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will offset losses from the drop in Brainstorm Cell's long position.
The idea behind Vaccinex and Brainstorm Cell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins